Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab
Mahsa Khayat-Khoei, Sarah Conway, Douglas A. Rubinson, Petr Jarolı́m, Maria K. Houtchens
Topics & Concepts
MedicineOcrelizumabSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationVirologyCoronavirus disease 2019 (COVID-19)ImmunologyCoronavirusAntibodyInternal medicineRituximabDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesPeripheral Neuropathies and Disorders